Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1919-1931
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1919
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1919
Table 6 Comparison of model for end-stage liver disease scores in two groups before and after autologous bone marrow infusion
| Group | Before | 1 mo | t/P value | 3 mo | t/P value | 6 mo | t/P value | 12 mo | t/P value |
| Control | 21.53 ± 6.17 | 18.87 ± 5.09 | 2.050/0.044 | 17.73 ± 6.42 | 2.631/0.010 | 13.76 ± 5.51 | 5.790/0.000 | 12.58 ± 4.64 | 7.147/0.000 |
| Intervention | 22.61 ± 5.61 | 18.92 ± 4.85 | 3.147/0.002 | 16.67 ± 5.75 | 4.677/0.000 | 15.42 ± 5.61 | 5.732/0.000 | 11.94 ± 5.00 | 8.980/0.000 |
| t | 0.804 | 0.044 | 0.770 | 1.325 | 0.577 | ||||
| P value | 0.424 | 0.965 | 0.443 | 0.189 | 0.566 |
- Citation: Liu BC, Cheng MR, Lang L, Li L, Si YH, Li AJ, Xu Q, Zhang H. Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study. World J Gastrointest Surg 2023; 15(9): 1919-1931
- URL: https://www.wjgnet.com/1948-9366/full/v15/i9/1919.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i9.1919